Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 28, 2017 13:02 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Pharmaceuticals Establishes Another Revenue Stream; Schedules First Patient with AAT Deficiency for Treatment in Mexico

BATON ROUGE, LA--(Marketwired - June 28, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
June 27, 2017 10:42 ET | Source: OncBioMune Pharmaceuticals, Inc.

Enrollment to Begin in OncBioMune's Trial of ProscaVax for Prostate Cancer in Mexico

BATON ROUGE, LA--(Marketwired - June 27, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of...
June 21, 2017 09:37 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Receives Patent Protecting Novel Cancer Vaccine in Mexico

BATON ROUGE, LA--(Marketwired - June 21, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of...
June 20, 2017 14:11 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Awarded Patent for ProscaVax in Japan

BATON ROUGE, LA--(Marketwired - June 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of...
June 19, 2017 11:55 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Acquires Norepinefrine for Low Blood Pressure and Heart Failure in Mexico from Teva Pharmaceuticals Mexico

MEXICO CITY, MEXICO--(Marketwired - June 19, 2017) - OncBioMune México, S.A. De C.V., (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the...
June 15, 2017 12:55 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune, AqVida add additional drugs to distribution agreement (Paclitaxel and Oxaliplatin)

BATON ROUGE, LA--(Marketwired - June 15, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
June 07, 2017 09:55 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Protects ProscaVax Cancer Treatment Technology in Hong Kong

BATON ROUGE, LA--(Marketwired - June 07, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
June 06, 2017 09:40 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune's Andfrt(R) Shown in Clinical Trial to Improve Sperm Count and Mobility

BATON ROUGE, LA--(Marketwired - June 06, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of...
June 01, 2017 08:30 ET | Source: OncBioMune Pharmaceuticals, Inc.

Protocol Submitted to FDA for Phase 2 Clinical Trial of ProscaVax as Immunotherapy for Early-Stage Prostate Cancer

BATON ROUGE, LA--(Marketwired - June 01, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
May 31, 2017 09:42 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Reports Record Monthly Sales for Bekunis(R) in May

BATON ROUGE, LA--(Marketwired - May 31, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...